# Johnson & Johnson (JNJ) — Q2-2013 Earnings Results

**Report date:** 2013-07-16 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2013

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.48 | N/A | +5.49% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their strategic direction. They emphasized the importance of innovation and maintaining market leadership.

**Key quotes:**

> Management highlighted strong performance in key product lines.

> They noted ongoing investments in innovation and R&D.

> The company remains focused on long-term growth despite market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Johnson & Johnson's strong EPS performance indicates better-than-expected profitability for the quarter. However, the lack of revenue data and guidance leaves some uncertainty about future growth. Investors will be looking for more clarity in upcoming reports to gauge the company's direction and stock performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2013_